Statute Details
- Title: Pharmacy Board Rules
- Act Code: PRA2007-R1
- Type: Subsidiary legislation (SL)
- Authorising Act: Pharmacists Registration Act (Chapter 230, Section 21)
- Current status: Current version as at 27 Mar 2026
- Revised edition / key dates (from legislative history): Revised Edition 1990; 25 Mar 1992 (25th March 1992)
- Key provisions (extract): Sections 1–6 (Citation, Secretary, Address, Meetings, Minutes, Absence from meetings)
What Is This Legislation About?
The Pharmacy Board Rules are procedural rules made under the Pharmacists Registration Act. In practical terms, they govern how the Pharmacy Board should conduct its internal business—how it convenes meetings, how it gives notice, how it records decisions, and what happens if a Board member repeatedly fails to attend.
Although the Rules are not about professional standards or licensing requirements directly, they are essential to the integrity of the Board’s work. Many Board functions—such as considering complaints or disciplinary matters—depend on fair process, proper notice, and accurate documentation. These Rules provide the “machinery” that supports those outcomes.
Because the Rules focus on governance and procedure, they are particularly relevant to practitioners who interact with the Board in disciplinary or administrative contexts. Even where the substantive law lies in the Pharmacists Registration Act and related regulations, the procedural validity of Board deliberations can be critical in disputes, appeals, or judicial review.
What Are the Key Provisions?
Section 1 (Citation) is straightforward: it states that the Rules may be cited as the Pharmacy Board Rules. While this seems minor, citation provisions are important for legal referencing, especially when multiple versions or related instruments exist.
Section 2 (Secretary) provides that the Board may elect one of its members to be its secretary. This is a governance provision: the secretary is the operational hub for meeting administration. In particular, the Rules later require that meeting notices be sent by the secretary, and that documents be supplied to members within specified timeframes. Practitioners should therefore treat the secretary’s role as central to procedural compliance.
Section 3 (Address) states that “the address of the Board shall be the address of the Chief Pharmacist of the Ministry of Health.” This determines where formal communications to the Board should be directed. In practice, this can matter for service of notices, submission of complaints, and correspondence relating to Board proceedings. If a party sends documents to the wrong address, procedural arguments may arise—particularly where timeliness or receipt is disputed.
Section 4 (Meetings of Board) sets out detailed procedural requirements for convening Board meetings:
(1) Notice of a meeting must be sent by the secretary “by letter addressed to each member.” This establishes a formal method of notification and implies that meetings should not be conducted without proper written notice to all members.
(2) Seven days’ notice for matters to be discussed: “At a meeting of the Board no matter shall be discussed unless 7 days’ notice thereof has been given to its members by the secretary.” This is a key fairness safeguard. It ensures that Board members have adequate time to consider issues before deliberation, reducing the risk of surprise or inadequate preparation.
(3) Disciplinary proceedings—document supply requirement: “No disciplinary proceedings against a pharmacist shall be considered at a meeting of the Board unless copies of all complaints against him and documents relevant thereto have been supplied to the members at least 7 days prior to the meeting.” This is one of the most important provisions for practitioners. It requires that, before the Board considers disciplinary matters, members must receive the complaint(s) and relevant documents in advance. The rule is designed to ensure informed decision-making and procedural fairness for the pharmacist subject to disciplinary proceedings.
Section 5 (Minutes) governs how Board proceedings must be recorded. Minutes are often the documentary backbone for later review of decisions. The section contains multiple layers of requirements:
(1) Recording and authentication: proceedings must be recorded in the form of minutes, and the minutes must be authenticated after confirmation at a meeting by the signature of the chairman at that meeting. This creates an evidentiary standard: minutes are not merely informal notes; they must be confirmed and signed.
(2) Content of minutes: minutes must contain “every motion and amendment thereof proposed and adopted or rejected,” including the names of every proposer and seconder. This level of detail supports transparency and accountability, and it can be crucial where decisions are later scrutinised.
(3) Omission of member comments: any comment or observation of a member on a motion may be omitted. This balances the need for formal decision records with practical limits on minute-taking.
(4) Amendments to minutes: any Board member may propose that the minutes be amended “in such manner as he thinks fit.” This allows correction of errors or refinement of the record, but it also means that the final authenticated minutes may differ from the initial draft.
(5) Formal statement when amending rules: if the Board proposes to amend any rule made under the Act, the minutes must record a formal statement on the purpose of the amendment. This ensures that rule changes are justified and traceable.
(6) Circulation of draft minutes: after adjournment for a day, a draft of the minutes must be sent to every member. This supports review and confirmation, and it reduces the risk that members are asked to confirm minutes without seeing the draft.
Section 6 (Absence from meetings) addresses attendance and accountability. If a Board member is absent without leave from three consecutive meetings, he “may be asked to resign.” This is a disciplinary/administrative consequence within the Board’s governance framework. While the provision uses discretionary language (“may be asked”), it signals that consistent participation is expected and that persistent absence can undermine Board functioning.
How Is This Legislation Structured?
The Pharmacy Board Rules are structured as a short set of provisions focused on Board administration. The instrument contains:
Section 1 (Citation) and Section 2 (Secretary) establish basic identification and internal office arrangements.
Section 3 specifies the Board’s address, linking it to the Chief Pharmacist of the Ministry of Health.
Section 4 provides the procedural framework for meetings, including notice requirements and special protections for disciplinary proceedings.
Section 5 sets out the requirements for minutes, including authentication, content, amendments, and circulation of drafts.
Section 6 provides a consequence for repeated unexcused absence.
Notably, the Rules do not set substantive disciplinary standards; instead, they ensure that the Board’s processes are conducted in a structured, documented, and fair manner.
Who Does This Legislation Apply To?
The Rules apply to the Pharmacy Board constituted under the Pharmacists Registration Act, and to its members in relation to Board meetings and internal governance. The provisions on notice, meeting agenda, disciplinary document supply, minutes, and attendance are directed at how Board members must operate collectively.
While the Rules do not directly impose obligations on pharmacists as such, pharmacists are indirectly affected because the Rules regulate how disciplinary proceedings may be considered. For example, the seven-day document supply requirement in Section 4(3) is designed to protect the procedural fairness of disciplinary processes. Practitioners representing pharmacists (or complainants) should therefore treat these Rules as relevant to the validity and fairness of the Board’s disciplinary deliberations.
Why Is This Legislation Important?
First, the Pharmacy Board Rules are a procedural safeguard. Disciplinary proceedings can have serious consequences for a pharmacist’s professional standing. Section 4(3) ensures that Board members receive complaints and relevant documents at least seven days before considering disciplinary matters. This reduces the risk of decisions being made without full information and supports fairness to the pharmacist.
Second, the Rules strengthen evidentiary reliability through strict minute-taking and authentication requirements. Section 5 requires minutes to be recorded, confirmed, and authenticated by the chairman’s signature. It also mandates detailed content (motions, amendments, and names of proposers and seconders). In practice, authenticated minutes can be critical when decisions are challenged, whether through internal review mechanisms, appeals, or judicial scrutiny.
Third, the Rules promote administrative discipline and continuity. The secretary’s role (Section 2) and the notice requirements (Section 4) create a predictable process. Section 6’s attendance mechanism helps ensure that the Board remains functional and that members do not repeatedly disengage without leave.
For practitioners, the key takeaway is that procedural compliance can be as important as substantive reasoning. Where disciplinary proceedings are considered without the required seven-day document supply, or where minutes are not properly authenticated and confirmed, the procedural legitimacy of the Board’s decision may be questioned.
Related Legislation
- Pharmacists Registration Act (Chapter 230), particularly Section 21 (authorising the making of the Pharmacy Board Rules)
Source Documents
This article provides an overview of the Pharmacy Board Rules for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.